General MedicationsORALGeneric
NAPROXEN SODIUM
NAPROXEN SODIUM
Standard Dose
EQ 200MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NAPROXEN SODIUM is listed in Drugs@FDA under application 215472 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient NAPROXEN SODIUM Form and strength CAPSULE;ORAL - EQ 200MG BASE Sponsor ONESOURCE SPECIALTY Submission history Latest submission status date: 2022-08-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview NAPROXEN SODIUM is listed in Drugs@FDA under application 215472 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NAPROXEN SODIUM Form and strength CAPSULE;ORAL - EQ 200MG BASE Sponsor ONESOURCE SPECIALTY Submission history Latest submission status date: 2022-08-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.